Trending News
Stop LA County fraud with forensic tracking of hospice and Botox money trails, protecting taxpayers and ensuring accountability.

Stop LA County Fraud: Hospice and Botox money trails

Los Angeles County has become the clearest case study in how Medicare and Medi-Cal money can be rerouted into luxury purchases, overseas accounts, and private jets with almost no patient care attached. Two separate enforcement waves in 2026—one state, one federal—laid bare the mechanics and the dollar amounts. The cases share the same geography, the same billing codes, and the same result: taxpayer dollars spent on assets that now sit in federal forfeiture lockers.

Identity brokers and 14 empty hospices

Operation Skip Trace centered on a ring that bought stolen identities on the dark web and used them to enroll out-of-state adults in Medi-Cal hospice benefits. Fourteen sham hospice companies filed claims from offices in Van Nuys, Tarzana, Glendale, Torrance, and Garden Grove. No nurses visited. No medications arrived. The only service rendered was the monthly submission of invoices.

State investigators say the scheme produced $267 million in false claims. Raids in April 2026 yielded $757,000 in cash and several unregistered handguns. So far, asset seizures and restitution orders have clawed back roughly $30 million, leaving more than $200 million unaccounted for. Prosecutors emphasize the absence of any clinical documentation, distinguishing this from routine upcoding disputes.

The companies shared addresses, phone numbers, and in some cases the same medical director. That clustering pattern is the same red flag state analysts have flagged across hundreds of other LA County hospices, yet regulators kept enrolling new providers until the volume of claims became impossible to ignore.

Live discharges as profit centers

Operation Never Say Die took aim at operators who kept patients on hospice rolls long after any terminal diagnosis could be justified. Topanga Hospice Care in Artesia billed Medicare more than $9 million and recorded an 85 percent live-discharge rate—five times the national average. St. Francis Palliative Care and 626 Hospice in Glendale posted a 97 percent five-year survival rate for a subset of their patients. Both figures triggered automatic audits, but the money had already moved.

Marketers recruited patients at churches, senior centers, and food banks, offering gift cards or transportation in exchange for enrollment signatures. Once certified, the hospices submitted claims for routine nursing visits that rarely occurred. Kickbacks flowed to referring physicians; surplus revenue financed mortgages, car notes, and vacations documented in court filings.

Eight people were arrested and fifteen charged across nine related investigations. Federal prosecutors described the operation as converting hospice licenses into cash-flow machines. The total alleged loss exceeds $50 million, a figure that will likely grow once forensic accountants finish tracing layered LLCs and nominee bank accounts.

Numbers that do not add up

LA County now hosts roughly 1,800 hospices. State data show 742 of them trigger multiple fraud indicators: billing twice the national average per patient, patient loads too small to support overhead, or sudden spikes in claims after changes in ownership. The typical LA hospice bills Medicare about $29,000 per patient; the national median is $13,000.

Dr. Rajiv Bhuva’s name appeared on claims for 2,800 patients across 126 different hospices in a single year. Regulators have not explained how one physician could certify that volume while maintaining an active practice. CMS responded by suspending hundreds of providers and imposing a six-month moratorium on new hospice enrollments in California and other high-risk states.

AG Rob Bonta has asked the legislature for dedicated funding to keep pace with the data analytics already used by insurers. Without it, he warned, enforcement will remain reactive, counting schemes only after the money has left the building.

From migraines to Cybertrucks

Parallel schemes have targeted Medicare’s outpatient drug benefit with equally stark results. In Glendale, physician Violetta Mailyan submitted claims for thousands of Botox injections she billed as migraine treatment. Pharmacy records, travel logs, and clinic security footage showed many of the procedures never took place. Medicare paid out $33 million on claims totaling more than $45 million.

Mailyan’s outlier status was extreme: she collected over $24 million in four years, six times the amount received by the next-highest provider in the same specialty. Court documents list a Tesla Cybertruck, a Model X, four residential properties, brokerage accounts worth $7.3 million, and a 17th-century crossbow among the forfeited items. She was convicted on twelve felony counts in May 2026.

The FBI’s Los Angeles field office called the case the largest Botox fraud scheme uncovered to date. The same data analytics that flagged hospice discharge rates caught the Botox billing pattern—identical CPT codes submitted on days the clinic was closed or the provider was out of the country.

Earlier warnings ignored

In 2022, the owner of multiple LA cosmetic clinics pleaded guilty to a $20 million insurance fraud involving Botox and laser procedures. Patients received “credits” for free services funded by false insurance claims. That scheme operated on a smaller scale but used the same playbook: bill for medically unnecessary procedures, move the cash into personal accounts, repeat.

Regulators treated the case as an outlier rather than a template. Three years later, Mailyan scaled the model by an order of magnitude. The gap between enforcement actions allowed the next operator to study the weaknesses and refine the camouflage.

Both cases relied on the same structural feature: Medicare’s fee-for-service model pays quickly and audits slowly. Once the electronic funds transfer clears, the money can be converted to real estate or luxury vehicles before investigators open a file.

Shared addresses, shared staff

Investigators now map hospices by GPS coordinates rather than corporate filings. In Van Nuys, multiple providers list the same suite number; staff move between locations carrying identical laptops pre-loaded with billing templates. The arrangement lets operators multiply claims without multiplying overhead, exactly the efficiency fraudsters seek.

CMS data show that when two hospices share a medical director and an office lease, average billing per patient rises 40 percent. The correlation is statistical, not diagnostic, but it narrows the field for auditors who cannot visit every site.

State licensing boards have shuttered about 280 hospices in recent years, yet new applications continue to arrive. The moratorium slows the influx, but it does not address the stock of existing providers whose ownership structures obscure ultimate control.

Task force and task force funding

The Vice President’s Anti-Fraud Task Force coordinated the April 2026 raids, pulling together the FBI, HHS-OIG, IRS-Criminal Investigation, and the FDA. The multi-agency model shortens the time between data anomaly and asset seizure, yet prosecutors still rely on tips and whistleblowers to identify the next cluster.

California’s budget request for dedicated fraud prosecutors sits in committee. Without it, the task force will rotate to the next hotspot, leaving local follow-up to offices already carrying heavy caseloads. The pattern mirrors earlier cycles in South Florida and Detroit, where enforcement surged, then plateaued once headlines faded.

Recovery rates remain low. Of the $267 million identified in Operation Skip Trace, less than one-eighth has been returned. Luxury assets sell at auction for fractions of their insured value, and cryptocurrency accounts traced to Eastern Europe have yielded little.

Patient impact and program trust

Every dollar paid for nonexistent hospice care is a dollar not available for patients who meet clinical criteria. Families report delayed admissions, reduced nursing visits, and pressure to enroll relatives who are stable. The damage is not only financial; it erodes confidence in a benefit designed for the final months of life.

Medicare’s hospice benefit was built on an honor system that assumed providers would self-select only eligible patients. The assumption failed when ownership shifted from mission-driven nonprofits to LLCs optimized for claims volume. Restoring integrity requires faster data review and real-time payment edits, not simply larger fines after the fact.

Beneficiaries cannot easily detect the fraud. A patient receives a Medicare summary notice listing services that never occurred, but most do not scrutinize the codes. By the time questions surface, the provider has closed, reopened under a new name, or relocated across county lines.

What changes and what stays

The 2026 moratorium and heightened screening will slow new entrants, yet the existing population of 1,800 hospices will require years of case-by-case review. Data analytics can flag outliers, but prosecution still depends on investigators who can translate billing anomalies into courtroom evidence.

Asset forfeiture has proven more effective than criminal fines alone. Seized properties and vehicles generate headlines and, occasionally, restitution checks. Still, the majority of proceeds from these schemes have already been spent or moved offshore, leaving taxpayers to absorb the loss.

LA County Fraud will continue to surface in federal dockets as long as the payment model rewards volume over verification. The next scheme will likely use different patient diagnoses or different billing codes, but the money trail will look familiar: claims filed, funds wired, assets purchased, then silence until the next audit cycle begins.

Next steps for detection

CMS has expanded predictive analytics contracts and increased sampling of high-risk claims before payment. California’s Department of Justice is hiring additional forensic accountants. Both moves address the lag between claim submission and review, yet neither closes the gap entirely.

Real-time edits that reject claims when a provider exceeds volume thresholds or when patient location data conflicts with service dates would cut off the cash flow before it starts. Implementing those edits requires legislative authority and vendor cooperation that have so far lagged behind the schemes themselves.

Until those controls are in place, the pattern repeats: a new LLC registers, a new medical director certifies, claims flow, and another round of luxury vehicles ends up in federal storage. The only variable is how long it takes investigators to connect the dots.

Share via: